WASATCH ADVISORS LP Q3 2018 Filing
Filed November 7, 2018
Portfolio Value
$8.8T
Holdings
231
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (231 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 201 | KINSKingstone Cos Inc. | 173,815 | $3.3B | 0.04% | |
| 202 | MYFWFirst Western Financial Inc. | 188,120 | $3.3B | 0.04% | |
| 203 | STIMNeuronetics Inc. | 101,500 | $3.3B | 0.04% | |
| 204 | SFBCSound Financial Bancorp Inc. | 81,257 | $3.2B | 0.04% | |
| 205 | —Entegra Financial Corp. | 119,152 | $3.2B | 0.04% | |
| 206 | CHKPCheck Point Software Technolog | 26,210 | $3.1B | 0.04% | |
| 207 | TENBTenable Holdings Inc. | 75,298 | $2.9B | 0.03% | |
| 208 | WNCWabash National Corporation | 157,830 | $2.9B | 0.03% | |
| 209 | AXASEURAbraxas Petroleum Corp. | 1,193,958 | $2.8B | 0.03% | |
| 210 | OZKBank OZK | 72,824 | $2.8B | 0.03% | |
| 211 | —Unum Therapeutics Inc. | 263,137 | $2.7B | 0.03% | |
| 212 | TNAVEURTelenav Inc. | 535,779 | $2.7B | 0.03% | |
| 213 | DMRCDigimarc Corp. | 85,820 | $2.7B | 0.03% | |
| 214 | OSSOne Stop Systems Inc. | 721,448 | $2.7B | 0.03% | |
| 215 | AQSTAquestive Therapeutics Inc. | 145,373 | $2.5B | 0.03% | |
| 216 | TCXTucows Inc. | 44,144 | $2.5B | 0.03% | |
| 217 | CUBICustomers Bancorp Inc. | 102,985 | $2.4B | 0.03% | |
| 218 | —ENSCO PLC | 249,197 | $2.1B | 0.02% | |
| 219 | GWRSGlobal Water Resources Inc. | 190,887 | $2.0B | 0.02% | |
| 220 | —RA Medical Systems Inc. | 108,585 | $2.0B | 0.02% | |
| 221 | AMBAAmbarella Inc. | 42,052 | $1.6B | 0.02% | |
| 222 | INSPInspire Medical Systems Inc. | 35,006 | $1.5B | 0.02% | |
| 223 | TGSTransportadora de Gas del Sur | 97,794 | $1.4B | 0.02% | |
| 224 | MEIPUSDMEI Pharma Inc. | 315,130 | $1.4B | 0.02% | |
| 225 | GGALGrupo Financiero Galicia SA | 51,632 | $1.3B | 0.02% | |
| 226 | DNLIDenali Therapeutics Inc. | 59,269 | $1.3B | 0.01% | |
| 227 | OPRXOptimizeRx Corp. | 69,116 | $1.2B | 0.01% | |
| 228 | CBNKCapital Bancorp Inc/MD | 94,644 | $1.2B | 0.01% | |
| 229 | —Cocrystal Pharma Inc. | 465,893 | $1.2B | 0.01% | |
| 230 | ATRAGBXAtara Biotherapeutics Inc. | 14,264 | $590.0M | 0.01% | |
| 231 | SUPVGrupo Supervielle SA | 40,222 | $309.0M | 0.00% |
PreviousPage 3 of 3